Check out the companies making headlines in the midday trading: Palantir – Stocks fell 13.4%. Palantir posted $884 million in first quarter revenues, while Analyst voted in pencil with LSEG at $863 million. However, earnings per share were 13 cents in line with Wall Street’s expectations. Ford Motor – The automaker reversed the previous decline by 3.2% higher than expected first-quarter results. Ford reported an adjusted earnings of 14 cents per share with revenues of $37.42 billion. Analysts surveyed by LSEG had forecast profits of 2 cents per share and revenues of $362.1 billion. Management has suspended guidance for 2025, citing “the possibility of disrupting the industry-wide supply chain that affects short-term risks, particularly production.” Upwork – Stocks on the freelance marketplace platform went 19% after reporting beats in both adjusted revenue and revenue for the first quarter. Upwork has also lifted its full-year guidance for adjusted revenue. Tesla – Electric vehicle inventory slipped 2% after data released Tuesday showed new car sales in the UK and Germany fell to their first drop in two years. In two countries each, sales fell sharply by 62% and 46% year-on-year, but demand for electric vehicles remained rising for both countries. HIMS & HERS HEALTH – Stocks rose 10.4% after TeleHealth Company reported first-quarter top-line and bottom-line beats. Revenues were 20 cents per share, surpassing consensus forecasts at 12 cents per share per LSEG. Revenue of $586 million also beat expectations of $538 million. HIMS led to lower than expected revenue in the second quarter. The telehealth provider predicted it would generate revenue between $530 million and $550 million, missing out on the $564.6 million that the analyst voted by FactSet was penciled in. Doordash – Stocks fell 6.8% after food distribution company’s first quarter revenue fell below the $309 million LSEG consensus. Doordash has also announced the $1.2 billion acquisition of restaurant reservation platform Sevenrooms. Neurocrine Biosciences – Biopharmaceutical inventory rose more than 9% after the company reported first quarter revenues above expectations. Sales of Ingrezza, which is used to treat motor disorders, also increased by 8% year-on-year to $545 million. Vertex Pharmaceuticals – Biotechnology stock plummeted 13.2% to the back of a weaker quarter results than expected. Adjusted earnings of $4.06 per share fell below the LSEG estimate of $4.32 per share. Revenue was $2.77 billion, with a loss of $2.855 billion forecast. CLOROX – Stocks of cleaning products manufacturers plunged 2.2% in weak fiscal results in the third quarter. Clorox reported an adjusted profit of $1.45 on revenue of $1.45 per share over the period. Analysts voted by LSEG expected revenues of $1.57 per share. Lattice Semiconductors – Chip stock fell 12.3% after both first quarter revenue and revenues were in line with consensus estimates. Lattice issued forward revenue guidance for the current quarter between $118.5 million and $128.5 million while analysts voted by LSEG predicted $123.6 million. Adjusted earnings are estimated to range from 22 cents per share to 26 cents per share, compared to analyst forecasts of 24 cents per share. Marriott International – Hotel and Resort Company added over 2% after posting top-line and bottom-line beats in the first quarter. Marriott reported adjusted earnings of $2.32 per share with revenue of $62.6 billion. Analysts surveyed by LSEG estimated a profit of $6.17 billion, with revenues of $2.25 per share. Constellation Energy – Oilstock revolved 11.4% by 11.4% with a top-line result that surpassed its first quarter forecast. Constellation reported revenue of $6.79 billion, exceeding the expected $5.44 billion by analysts surveyed by Factset. – Reported by CNBC’s Lisa Kailai Han, Michelle Fox, Alex Harring and Sean Conlon.
